LPTX: leaptx.com Cash Calculated per Single Share

Leap Therapeutics - graphic logo of issuer LPTX

The stability of Leap Therapeutics, Inc. (LPTX) is based on clinical trials of antibodies against gastric cancer and support from pharmaceutical giants. This cash position per share chart confirms liquidity, where 0.32 shows the value of this parameter. This enables the attraction of leading oncologists through generous funding. Ultimately, the company's success relies on the synergy of DKN-01 with inhibitors in intestinal tumor research.

Leap Therapeutics Inc (LPTX) - Cash per Share from 07/04/2022 to 11/13/2025

Comprehensive metric breakdowns and analytics for Leap Tx (LPTX)

- current quotes and average value forecast:
- cash availability and cash flow indicators:
Comprehensive company analysis:Leap Tx (LPTX)
Flagship merchandise of Leap Therapeutics Inc

This metric is calculated by dividing the total volume of liquid assets by the number of shares outstanding. It measures the actual cash backing of each equity share, determining the issuer's financial autonomy. By analyzing the cash per share level, an investor assesses the ability of Leap Therapeutics, Inc. (LPTX) to fund tumor immunotherapy developments prior to finalizing licensing deals. An optimal balance of reserves ensures the company's survival amid high market demand. The stability of this metric confirms the resilience of the investment profile.